{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-154262","form_type":"8-K","ticker":null,"cik":"0001966494","company_name":"CARGO Therapeutics, Inc.","filed_at":"2024-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.332912+00:00","generated_at":"2026-06-01T06:37:48.139286+00:00","sec_items":["5.02","5.07"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"CARGO Therapeutics appoints Jane Pritchett Henderson to board, expands to 8 directors","bullets":["Board expanded from 7 to 8; Henderson appointed as Class III director through 2026 annual meeting.","Henderson currently CFO of Apogee Therapeutics; will serve on Audit and Compensation Committees.","Receives standard non-employee director compensation: $40k annual retainer plus option grants.","At June 4 annual meeting, stockholders elected Viswanadhan and Huber as Class I directors.","Ratified Deloitte & Touche as independent auditor for FY2024 with 26,079,444 votes for, 1,081 against."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-154262","json":"https://secwatch.observer/filing/0001193125-24-154262.json","markdown":"https://secwatch.observer/filing/0001193125-24-154262.md","text":"https://secwatch.observer/filing/0001193125-24-154262.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1966494/000119312524154262/0001193125-24-154262-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1966494/000119312524154262/d844498d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:37:48.139286+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"837da3f3bc","claim":"Jane Pritchett Henderson was appointed as Director at CARGO Therapeutics, Inc..","evidence_excerpt":"On June 3, 2024, the Board of Directors (the “Board”) of CARGO Therapeutics, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, approved an increase in the number of authorized directors on the Board from seven to eight and appointed Jane Pritchett Henderson to the Board to fill the vacancy resulting from such increase.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1966494/000119312524154262/0001193125-24-154262-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}